Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SALT LAKE CITY, Aug. 15, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be sponsoring, presenting and hosting a booth at the 16th Annual Next Generation Dx Summit, held virtually and in-person in Washington, D.C. on August 19-21, 2024.

Cambridge Healthtech Institute’s Next Generation Dx Summit is described as the nexus for international thought leaders to discuss diagnostic advancement and technology innovation, and offers a valuable window into how point-of-care, decentralized testing, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care.

On Monday, August 19, at 12:15 PM ET, Company CEO Dwight Egan will be presenting on the Company’s forthcoming PCR platform, which is currently under FDA review and is not currently for sale, in a luncheon presentation titled “Co-Dx PCR Platform: The Future of Accessible Diagnostics.”

Attendees are invited to visit the Company at Booth #26 to learn more about the upcoming Co-Dx PCR testing platform as well as the Co-Dx Logix Smart® suite of clinical laboratory solutions. These solutions include Research Use Only (RUO) tests for mpox** virus, one of which was included in a study published in the Oxford Academic journal Open Forum Infectious Diseases in December, 2023. Yesterday, the World Health Organization Director-General declared mpox a public health emergency of international concern (PHEIC).

To learn more about the summit, including in-person and virtual registration details, please visit https://www.nextgenerationdx.com.

*The Co-Dx PCR platform (including the PCR Home™, PCR Pro™, mobile app, and all associated tests) is subject to review by the FDA and/or other regulatory bodies and is not available for sale. The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA and are not available for sale.

**The Co-Dx Logix Smart® Mpox and Co-Dx Logix Smart® Mpox 2-Gene tests are for Research Use Only. Not for use in diagnostic procedures.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-present-at-16th-next-generation-dx-summit-in-washington-dc-302223138.html

SOURCE Co-Diagnostics

Staff

Recent Posts

SurgiBox Achieves CE Mark for SurgiField System Devices to Improve Access to Safe Surgery at the Point of Need

CE Certification positions SurgiBox for global expansion and robust sales acceleration CAMBRIDGE, Mass., Aug. 7,…

27 minutes ago

Atlanta Facial Plastic Surgeon and Bitcoin Advocate Dr. Benjamin Stong Featured on The Bitcoin Fellowship Show

Headline Summary: Dr. Benjamin Stong, founder of Kalos Facial Plastic Surgery in Atlanta, was recently…

27 minutes ago

Healthcare Outcomes Performance Company acquires Caro Health to advance AI-powered healthcare innovation and accelerate global growth

Acquisition integrates advanced AI-driven patient engagement and operational tools into HOPCo's expanding digital health and…

27 minutes ago

Why Health Literacy for Kids Matters: How Know Yourself Academy Helps Children Learn About Their Bodies, Health Habits, and Wellness

SANTA BARBARA, Calif., Aug. 7, 2025 /PRNewswire/ -- Every day, parents remind their kids: brush…

27 minutes ago

Alleva Reinvents Insurance Verification for Behavioral Health Providers

LAGUNA NIGUEL, Calif., Aug. 7, 2025 /PRNewswire/ -- Alleva, the premier EMR platform for behavioral…

28 minutes ago